Streptomyces mediterranei mutant capable of production of rifamycin B

Information

  • Patent Grant
  • 4267274
  • Patent Number
    4,267,274
  • Date Filed
    Thursday, June 13, 1974
    50 years ago
  • Date Issued
    Tuesday, May 12, 1981
    43 years ago
Abstract
A biologically pure culture of Streptomyces mediterranei mutant strain 18, ATCC.
Description

BACKGROUND OF THE INVENTION
It has previously been reported that during fermentation in normal growth media, Streptomyces mediterranei synthesizes a family of antibiotics collectively referred to as the rifamycin complex (P. Sensi, et al., Antibiotics Annual 1959-1960, page 262). Subsequent work revealed that the addition of sodium diethyl barbiturate to the culture medium resulted essentially in the formation of a single fermentation product, rifamycin B (Margalith P. and Pagani H., Applied Microbiology, 9, 325, 1961).
SUMMARY OF THE INVENTION
The present invention relates to the isolation of a mutant strain of Streptomyces mediterranei and the elaboration by it of essentially rifamycin B only, irrespective of the presence or absence of sodium diethyl barbiturate in the fermentation medium, so that an improved process for making rifamycin B results. The rifamycin B is recovered from the fermentation medium in a conventional manner.





DESCRIPTION OF SOME PREFERRED EMBODIMENTS
The following is a written description of the invention and of the manner and process of making and using it to enable the art skilled to make and use the same and sets forth the best mode contemplated by the inventors of carrying out their invention.
Isolation of Mutant Strain
A suspension of spores of Streptomyces mediterranei ATCC 13685 was treated with N-methyl-N'-nitroso-N-nitroguanidine at 1 mg/ml in a pH 9.0 tris(hydroxymethyl)aminomethane buffer for 60 minutes at 28.degree. C. The mutagen-treated spores were then washed and plated onto Petri dishes containing Bennett agar. After 14 days incubation at 28.degree. C., the surviving colonies were picked off and examined for their ability to produce rifamycin B in liquid medium with and without sodium diethyl barbiturate. The mutant producing high quantities of rifamycin B in the absence of sodium diethyl barbiturate was further examined. Such mutant was called M 18 and deposited with the ATCC under the number 21789 and its characteristics will be described later in detail.
Fermentation
An industrial strain of Streptomyces mediterranei ATCC 13685 and strain M 18 were propagated on Bennett agar for 6 to 8 days at 28.degree. C. The vegatative medium was inoculated with a slant of Bennett agar (1/2 slant per flask) and the flasks were incubated on a rotary shaker at 28.degree. C. for 72 hours. The vegetative medium used contained:
______________________________________Beef extract 5 g.Yeast extract 5 g.Poptone 5 g.Gasein hydrolyzate 3 g.NaCl 1.5 g.H.sub.2 O to make 1 liter______________________________________
The pH was adjusted to 7.3 with NaOH. An amount of 100 ml. vegetative medium was used in 500 ml. Erlenmeyer flasks. After 72 hours growth the vegetative medium was used to inoculate (5% v/v) the fermentation medium.
Two fermentation media were used:
RFB 744: a synthetic medium
RFB 2244: a complex medium
Fermentation were always carried out using 50 ml. of medium in a 500 ml. Erlenmeyer flask.
The composition of the two media was as follows:
______________________________________RFB 744Glucose 96 g.(NH.sub.4).sub.2 SO.sub.4 15 g.KH.sub.2 PO.sub.4 2 g.MgSO.sub.4 . 7H.sub.2 O 1 g.CaCO.sub.3 17 g.CuSO.sub.4 . 5H.sub.2 O 0.0033 g.FeSO.sub.4 . 7H.sub.2 O 0.01 g.ZnSO.sub.4 . 7H.sub.2 O 0.05 g.MnSO.sub.4 . 4H.sub.2 O 0.04 g.CoCl.sub.2 . 6H.sub.2 O 0.002 g.(NH.sub.4).sub.6 Mo.sub.7 O.sub.24 . 4H.sub.2 O 0.001 g.Sodium diethyl barbiturate 2 g.H.sub.2 O 1000 ml.pH before sterilizing 6.8pH after sterilizing 6.3RFB 2244Glucose 126.5 g.Propylene glycol 5 g.CaCO.sub.3 9.5 g.Peanut flour 25 g.Soybean flour 10 g.(NH.sub.4).sub.2 SO.sub.4 1 g.MgSO.sub.4 . 7H.sub.2 O 1 g.FeSO.sub.4 . 7H.sub.2 O 0.01 g.CuSO.sub.4 . 5H.sub.2 O 0.0033 g.ZnSO.sub.4 . 7H.sub.2 O 0.050 g.MnSO.sub.4 . 5H.sub.2 O 0.004 g.CoCl.sub.2 . 6H.sub.2 O 0.002 g.(NH.sub.4).sub.6 Mo.sub.7 O.sub.24 . 4H.sub.2 O 0.001 g.Sodium diethyl barbiturate 1.5 g.pH before sterilization 7.4corrected with 15% NaOHpH after sterilization 6.2-6.3Antifoam A silicone defoamer 0.2 ml. per flask containing 50 ml. of growth medium______________________________________ The same media were prepared without the addition of sodium diethyl barbiturate to carry out comparative fermentations. The fermentation conditions and rates are given in Tables 1 and 2 together with the obtained rifamycin B yields.
TABLE 1______________________________________ Rifamycin B in medium, 82 g/mlStrain with barbiturate without barbiturate______________________________________StreptomycesmediterraneiATCC 13685 2210 <390*Mutant M 18ATCC 21789 2290 2240______________________________________ The fermentation medium used was RFB 2244 with and without 1.5 g. of sodium diethyl barbiturate per liter at a temperature of 28.degree. C. an a fermentation period of 190 hours. *This result represents an upper limit for the amount of rifamycin B present, as the presence of rifamycin complex in the comparative medium interferes with the normal assay.
TABLE 2______________________________________ Rifamycin B (.mu.g/ml) Rifamycin complex (.mu.g/ml) with without with withoutStrain barbiturate barbiturate______________________________________StreptomycesmediterraneiATCC 13685 344 <107 <10 99Mutant M 18ATCC 21789 580 513 <10 <10______________________________________ The fermentation medium used was RFB 744 with and without 1.5 g. per lite of sodium diethyl barbiturate. Fermentation time was 144 hours at 28.degree. C. on a rotary shaker.
Assay of Rifamycin B
The rifamycin B content of the filtered broths was assayed by a differential spectrophotometric technique described by Pasqualucci, et al., Journal of Pharmaceutical Sciences 59, 685, 1970.
Estimation of Rifamycin Complex
Samples of fermentation medium were adjusted to pH 2.0 with hydrochloric acid and extracted with ethyl acetate. The organic extract was then extracted with the phosphate buffer, pH 7.38; under these conditions rifamycin B is extracted by the buffer whereas the rifamycin complex remains in the exhausted organic phase. The rifamycin complex in the exhausted ethyl acetate was estimated spectrophotometrically by measuring the optical density at 460 m.mu. of an aliquot suitably diluted in ethyl alcohol containing 1% ascorbic acid.
In industrial practice, the product rifamycin B is recovered from a fermented broth in usual ways.
Description of Streptomyces Mediterranei M 18 ATCC 21789
For the investigation of growth characteristics, Str. mediterranei and its mutant strain M 18 were grown in a variety of standard media according to Gottlieb and Shirling, (Methods of Characterization of Streptomyces Species, Intern. J. Syst. Bact. 16, 313-340, 1966); and, in addition, some media recommended by Waksman were used (The Actinomycetes, Vol. II, Williams and Wilkins Co., 1961).
The following Tables report the growth characteristics and properties of the mutant strain M 18 ATCC 21789 and of Streptomyces mediterranei ATCC 13685.
TABLE 3______________________________________Assimilation of carbon compounds by streptomycesmediterranei and mutant M 18 Streptomyces mediterranei Mutant M 18Carbon Sources ATCC 13685 ATCC 21789______________________________________Inositol ++ ++Fructose ++ ++Rhamnosed ++ ++Xylose ++ ++Raffinose - -Arabinose ++ ++Cellulose - -Sucrose (positive control) ++ ++No carbon (negative control) - -______________________________________
TABLE 4__________________________________________________________________________Comparison of morphologic and growth properties of StreptomycesmediterraneiATCC 13685 and mutant M 18 ATCC 21789Media Streptomyces mediterranei ATCC 13685 Streptomyces mediterranei M 18 ATCC__________________________________________________________________________ 21789Oat meal agar Fair growth with smooth surface. Abundant growth with smooth surface. Vegetative mycelium hyaline to yellowish Vegetative mycelium greenish to orange with pinkish reverse. Whitish aerial with amber shadow. Aerial mycelium mycelium with pinkish reverse. Traces absent. Yellow green soluble pigment. of yellowish soluble pigment.Yeast extract Abundant growth yellowish to pink with Abundant growth with wrinkled surface.glucose agar rough surface. Scanty aerial mycelium. Vegetative mycelium amber brown with(medium No. 2 No pigmentation of medium. orange brown edges. Traces of pinkishGottlieb and aerial mycelium. Deep amber brown solu-Shirling) ble pigment.Emerson glucose Abundant growth, yellowish to pink orange Abundant growth with smooth surface.agar with rough surface. Scanty aerial Orange vegetative mycelium. No aerial mycelium becomes pinkish. No pigmenta- mycelium. Golden yellow soluble pigment. tion of medium.Bennett's agar Good growth, yellowish turning orange Abundant growth with very wrinkled surface. yellow. Aerial mycelium becoming Vegetative mycelium amber brown with pinkish. Light amber pigment. orange brown edges. Traces of pinkish aerial mycelium. Deep amber brown soluble pigment.Penassay agar Poor growth. Abundant growth with thin and smooth sur- face. Vegetative mycelium light orange. No aerial mycelium. Traces of light yellow soluble pigment.Pridham's agar Moderate growth; smooth, colorless Abundant growth with smooth surface. Vege- with lobster red spots. Pink aerial tative mycelium light orange with small mycelium. No pigmentation of medium. patches of brick red color. Traces of pink aerial mycelium. Yellow soluble pig- ment.Starch agar Poor growth, colorless to light orange Abundant growth with smooth surface. Vege-(Medium No. 4 pink. Scarce white aerial mycelium. tative mycelium deep orange with brownishGottlieb and Starch hydrolysis: doubtful. tinge. Abundant pink aerial mycelium.Shirling) Chrome yellow soluble pigment. Starch hydrolysis: negative.Dextrose tryptone Abundant growth, orange pink with Abundant growth with wrinkled surface.agar golden yellow to orange reverse. Orange vegetative mycelium. No aerial Pinkish aerial mycelium. Light mycelium. Yellow soluble pigment. golden yellow soluble pigment.Hickey's and Moderate growth, hyaline to light Abundant growth with smooth surface.Tresner's cobalt pinkish orange. Some pinkish aerial Vegatative mycelium amber rose. Tracesagar mycelium. Some yellowish soluble of pinkish aerial mycelium. Amber rose pigment. soluble pigment.Tyrosine agar Poor growth. Abundant growth with wrinkled surface.(Medium No. 7 Vegetative mycelium deep orange withGottlieb and brownish tinge. Aerial mycelium absent.Shirling) Yellow soluble pigment. Tyrosinase reaction: strongly positive.Ca malate agar Fair growth, colorless. Aerial Fair growth with smooth surface Vegeta- mycelium whitish with pink tinge. tive light orange mycelium. No aerial No soluble pigment. Partial mycelium. Light lemon yellow soluble pig- digestion of Ca malate. ment. Scarce digestion of Ca malate.Gelatine No pigmentation. No pigmentation. Liquefaction: positive. Liquefaction: slow and incomplete.Yeast extract Abundant rough growth colorless to Abundant growth with a very wrinkled sur-molasses agar yellowish, whitish aerial mycelium. face. Vegetative mycelium burnt brown Deep amber soluble pigment. with orange brown edges. Traces of pink aerial mycelium. Deep yellow ochre solu- ble pigment.Czapek-Dox glucose Poor growth, thin and colorless to Abundant growth with smooth surface.agar light melon. Traces of pinkish white Vegetative mycelium light orange. No aerial mycelium. No soluble pigment. aerial mycelium. Light lemon yellow soluble pigment.Potato agar Poor growth, thin and colorless. Abundant growth with smooth surface. Traces of Whitish aerial mycelium. Amber rose vegetative mycelium. No soluble pigment.Glucose asparagine Fair growth with smooth surface. Thin Abundant growth with smooth surface.agar vegetative mycelium of light orange pink Orange vegetative mycelium. No aerial color and yellowish reverse. No aerial mycelium. Traces of lemon yellow soluble mycelium. Some light yellow soluble pigment. pigment.Asparagine agar Fair growth with smooth surface. Thin Abundant growth with thin and smooth sur-(Medium No. 5 vegetative mycelium of light orange face. Light orange vegetative mycelium.Gottlieb and pink color and yellowish reverse. No No aerial mycelium. No soluble pigment.Shirling) aerial mycelium. Some light yellow soluble pigment.Nutrient agar Moderate growth with smooth surface; Abundant growth with smooth surface. melon to orange with yellowish orange Orange vegetative mycelium. No aerial reverse. Aerial mycelium pinkish mycelium. Light yellow soluble pigment. white. Soluble pigment absent.Nitrate broth Surface growth with pinkish aerial Surface growth with pinkish aerial mycelium. No reduction to nitrites. mycelium. Reduction of nitrates. Broth Broth becomes yellowish. becomes yellowish.Litmus milk No peptonization or coagulation. No coagulation, no peptonization. Slight alkaline reaction.Skim milk agar Abundant growth with smooth surface. Abundant growth with smooth surface. Vegetative mycelium orange. Cascin Vegetative mycelium orange. Golden yellow hydrolysis; positive. Pink aerial soluble pigment. No aerial mycelium. mycelium. No soluble pigment. Casein hydrolysis: strongly positive.Peptone-yeast Moderate growth with smooth surface. Moderate growth with thin and smooth sur-extract iron agar Colorless vegetative mycelium. Traces face. Colorless vegetative mycelium.(Medium No. 6 of whitish aerial mycelium. No soluble No aerial mycelium. No soluble pigment.Gottleib and pigment. H.sub.2 S production: negative. H.sub.2 S production: negative.Shirling)__________________________________________________________________________ NOTE: Color determination was performed using the method of Maerz and Paul, Dictionary of Color, McGrawHill, Inc., N.Y., 1950.
Claims
  • 1. A biologically pure culture comprising a new microorganism mutant identified as Streptomyces mediterranei M 18, ATCC 21789, and a nutrient medium consisting essentially of an assimilable carbon source, an assimilable nitrogen source and essential mineral salts, said culture being capable of producing rifamycin B in a recoverable quantity upon fermentation.
  • 2. A biologically pure culture of Streptomyces mediterranei, mutant strain 18, (ATCC 21789) capable of producing rifamycin B in a recoverable quantity upon fermentation.
Parent Case Info

This is a division of application Ser. No. 354,811 filed Apr. 26, 1973 now U.S. Pat. No. 3,871,965.

US Referenced Citations (1)
Number Name Date Kind
3150046 Sensi et al. Sep 1964
Non-Patent Literature Citations (1)
Entry
Martin Frolisher; Fundamentals of Microbiology; p. 185 8th edition (1968).
Divisions (1)
Number Date Country
Parent 354811 Apr 1973